Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis

Déc. 31, 2024 31 Déc. 2024 at 5:00 PM EST

S. Grinspoon , L. Fourman , T Stanley , D. Benkeser , C. McGary , R.B. Cash